Aquestive Therapeutics (AQST) Debt to Equity (2017 - 2026)
Aquestive Therapeutics (AQST) recorded quarterly Debt to Equity of -$1.14 in Q1 2026, down 2.13% quarter-over-quarter from -$1.11 in Q4 2025, and down 105.34% on a YoY basis from $21.31 in Q1 2025.
Aquestive Therapeutics (AQST) Debt to Equity (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Debt to Equity history runs 10 years deep, the most recent figure standing at -$1.14 for Q1 2026.
- In Q1 2026, Debt to Equity fell 105.34% year-over-year to -$1.14; the TTM figure through Mar 2026 stood at -$1.14 (down 105.34% YoY), while the FY2025 annual figure was -$1.11, down 106.11% from the prior year.
- Debt to Equity was -$1.14 for Q1 2026 at Aquestive Therapeutics, down from -$1.11 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.26 in Q4 2023 to a low of -$8.83 in Q3 2025.
- Historically, Debt to Equity has averaged -$1.05 across 5 years, with a median of -$0.49 in 2024.
- The sharpest annual moves came in 2023 and 2025: Debt to Equity surged 41.23% in 2023, then slumped 2025.6% in 2025.
- A 5-year view of Debt to Equity shows it stood at -$0.44 in 2022, then surged by 41.23% to -$0.26 in 2023, then slumped by 109.14% to -$0.54 in 2024, then tumbled by 106.11% to -$1.11 in 2025, then decreased by 2.13% to -$1.14 in 2026.
- The last three Debt to Equity figures came in at -$1.14 (Q1 2026), -$1.11 (Q4 2025), and -$8.83 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | -1.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 |
| Dec 31, 2025 | -1.11 |
| Sep 30, 2025 | -8.83 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.55 |
| Dec 31, 2024 | -0.54 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -0.79 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -0.38 |
| Jun 30, 2023 | -0.37 |
| Mar 31, 2023 | -0.39 |
| Dec 31, 2022 | -0.44 |
| Sep 30, 2022 | -0.49 |
| Jun 30, 2022 | -0.56 |
| Mar 31, 2022 | -0.58 |
| Dec 31, 2021 | -0.65 |
| Sep 30, 2021 | -0.67 |
| Jun 30, 2021 | -0.73 |